Apixaban versus aspirin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a predefined subgroup analysis from AVERROES, a randomised trial
Open accessAbstract
Background In the AVERROES study, apixaban, a novel factor Xa inhibitor, reduced the risk of stroke or systemic embolism in patients with atrial fibrillation who were at high risk of stroke but unsuitable for vitamin K antagonist therapy. We aimed to investigate whether the subgroup of patients with previous stroke or transient ischaemic attack (TIA) would show a greater benefit from apixaban compared with aspirin than would patients without previous cerebrovascular events.Methods In AVERROES, 5599 patients (mean age 70 years) with atrial fibrillation who were at increased risk of stroke and unsuitable for vitamin K antagonist therapy were randomly assigned to receive apixaban (5 mg twice daily) or aspirin (81-324 mg per day). The mean follow-up was 1·1 years. The primary efficacy outcome was stroke or systemic embolism; the primary safety outcome was major bleeding. Patients and investigators were masked to study treatment. In this prespecified subgroup analysis, we used Kaplan-Meier estimates of 1-year event risk and Cox proportional hazards regression models to compare the effects of apixaban in patients with and without previous stroke or TIA. AVERROES is registered at ClinicalTrials.gov, number NCT00496769.Findings In patients with previous stroke or TIA, ten events of stroke or systemic embolism occurred in the apixaban group (n=390, cumulative hazard 2·39% per year) compared with 33 in the aspirin group (n=374, 9·16% per year; hazard ratio [HR] 0·29, 95% CI 0·15-0·60). In those without previous stroke or TIA, 41 events occurred in the apixaban group (n=2417, 1·68% per year) compared with 80 in the aspirin group (n=2415, 3·06% per year; HR 0·51, 95% CI 0·35-0·74). The p value for interaction of the effects of aspirin and apixaban with previous cerebrovascular events was 0·17. Major bleeding was more frequent in patients with history of stroke or TIA than in patients without (HR 2·88, 95% CI 1·77-4·55) but risk of this event did not differ between treatment groups.Interpretation In patients with atrial fibrillation, apixaban is similarly effective whether or not patients have had a previous stroke or TIA. Given that those with previous stroke or TIA have a higher risk of stroke, the absolute benefits might be greater in these patients.Funding Bristol-Myers Squibb and Pfizer.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Long-term oral anticoagulation with a VKA or NOAC conveys benefits in AF patients who survived a stroke.
“Long-term OAC with a VKA 363,[479][480][481] or NOAC 482 conveys benefits in AF patients who survived a stroke.”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [363]
Cites
Guidelines for the management of atrial fibrillation
Authors/Task Force Members, Camm, A. J., Kirchhof, P. F., Lip, G. Y. H., Schotten, U., Savelieva, I., Ernst, S., Gelder, I. C. V., Al‐Attar, N., Hindricks, G., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq278 · Cited by 5,875 · see citing works
Self-citationHart, R. G., Pearce, L. A., & Aguilar, M. I. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-12-200706190-00007 · Cited by 4,793 · see citing works
Self-citationApixaban in patients with atrial fibrillation
Connolly, S. J., Eikelboom, J., Joyner, C., Diener, H.-C., Hart, R., Golitsyn, S., Flaker, G., Avezum, A., Hohnloser, S. H., Diaz, R., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1007432 · Cited by 2,483 · see citing works
Self-citationEffect of clopidogrel added to aspirin in patients with atrial fibrillation
The ACTIVE Investigators (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0901301 · Cited by 2,102 · see citing works
EAFT (European Atrial Fibrillation Trial) Study Group (1993) · The Lancet · doi:10.1016/0140-6736(93)92358-z · Cited by 1,877 · see citing works
Mant, J., Hobbs, F. R., Fletcher, K., Roalfe, A., Fitzmaurice, D., Lip, G. Y., & Murray, E. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61233-1 · Cited by 1,556 · see citing works
Self-citationWann, L. S., Curtis, A. B., January, C. T., Ellenbogen, K. A., Lowe, J. E., Estes, N. A. M., Page, R. L., Ezekowitz, M. D., Slotwiner, D. J., Jackman, W. M., et al. (2010) · Circulation · doi:10.1161/cir.0b013e3181fa3cf4 · Cited by 1,338 · see citing works
Oral Anticoagulants vs Aspirin in Nonvalvular Atrial Fibrillation
van Walraven, C., Hart, R. G., Singer, D. E., Laupacis, A., Connolly, S. J., Petersen, P., Koudstaal, P. J., Chang, Y., & Hellemons, B. S. P. (2002) · JAMA · doi:10.1001/jama.288.19.2441 · Cited by 715 · see citing works
Self-citationCalculating the number needed to treat for trials where the outcome is time to an event
Altman, D. G., & Andersen, P. K. (1999) · BMJ · doi:10.1136/bmj.319.7223.1492 · Cited by 710 · see citing works
Why Do Patients With Atrial Fibrillation Not Receive Warfarin?
Bungard, T. J., Ghali, W. A., Teo, K. K., McAlister, F. A., & Tsuyuki, R. T. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.1.41 · Cited by 593 · see citing works
Independent predictors of stroke in patients with atrial fibrillation
The Stroke Risk in Atrial Fibrillation Working Group (2007) · Neurology · doi:10.1212/01.wnl.0000267275.68538.8d · Cited by 545 · see citing works
Wann, L. S., Curtis, A. B., Ellenbogen, K. A., Estes, N. A. M., Ezekowitz, M. D., Jackman, W. M., January, C. T., Lowe, J. E., Page, R. L., Slotwiner, D. J., et al. (2011) · Circulation · doi:10.1161/cir.0b013e31820f14c0 · Cited by 398 · see citing works
Warfarin Discontinuation After Starting Warfarin for Atrial Fibrillation
Fang, M. C., Go, A. S., Chang, Y., Borowsky, L. H., Pomernacki, N. K., Udaltsova, N. V., & Singer, D. E. (2010) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.110.937680 · Cited by 185 · see citing works
Eikelboom, J. W., O'Donnell, M. J., Yusuf, S., Díaz, R., Flaker, G. C., Hart, R. G., Hohnloser, S. H., Joyner, C. D., Lawrence, J., Pais, P., et al. (2010) · American Heart Journal · doi:10.1016/j.ahj.2009.08.026 · Cited by 163 · see citing works
Self-citationApixaban, an oral, direct inhibitor of activated Factor Xa.
Shantsila, E., & Lip, G. Y. H. (2008) · PubMed · Cited by 51 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomström‐Lundqvist, C., Boriani, G., Castella, M., Dan, G.-A., Dilaveris, P., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa612 · Cited by 10,225 · see citing works
Self-citation2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P. F., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castellà, M., Diener, H., Heidbüchel, H., Hendriks, J., et al. (2016) · EP Europace · doi:10.1093/europace/euw295 · Cited by 6,438 · see citing works
Self-citation2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw210 · Cited by 6,418 · see citing works
Self-citationMeschia, J. F., Bushnell, C., Boden-Albala, B., Braun, L. T., Bravata, D. M., Chaturvedi, S., Creager, M. A., Eckel, R. H., Elkind, M. S. V., Fornage, M., et al. (2014) · Stroke · doi:10.1161/str.0000000000000046 · Cited by 2,650 · see citing works
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezw313 · Cited by 1,403 · see citing works
Self-citationOsmancik, P. P., Heřman, D., Neužil, P., Hála, P., Táborský, M., Kala, P., Poloczek, M., Šťásek, J., Haman, L., Branny, M., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.04.067 · Cited by 654 · see citing works
Sharma, M., Cornelius, V. R., Patel, J. P., Davies, G., & Molokhia, M. (2015) · Circulation · doi:10.1161/circulationaha.114.013267 · Cited by 241 · see citing works
Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation
Camm, A. J., Accetta, G., Ambrosio, G., Atar, D., Bassand, J., Berge, E., Cools, F. J. S., Fitzmaurice, D. A., Goldhaber, S. Z., Goto, S., et al. (2016) · Heart · doi:10.1136/heartjnl-2016-309832 · Cited by 240 · see citing works
Silent Brain Infarction and Risk of Future Stroke
Gupta, A. K., Giambrone, A. E., Gialdini, G., Finn, C. B., Delgado, D., Gutierrez, J., Wright, C. B., Beiser, A., Seshadri, S. S., Pandya, A., et al. (2016) · Stroke · doi:10.1161/strokeaha.115.011889 · Cited by 233 · see citing works
2020 Clinical guidelines for Atrial fibrillation and atrial flutter
Arakelyan, M. S., Bockeria, L. A., Vasilieva, E., Sp, G., Golukhova, E. Z., Gorev, M. V., Davtyan, K. V., Drapkina, O. M., Станиславовна, К. Е., Kuchinskaya, Е. А., et al. (2021) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2021-4594 · Cited by 255 · see citing works
Apixaban to Prevent Recurrence After Cryptogenic Stroke in Patients With Atrial Cardiopathy
Kamel, H., Longstreth, W. T., Tirschwell, D., Kronmal, R. A., Marshall, R. S., Broderick, J. P., García, R. A., Plummer, P., Sabagha, N., Pauls, Q., et al. (2024) · JAMA · doi:10.1001/jama.2023.27188 · Cited by 220 · see citing works
Windecker, S., Stortecky, S., & Meier, B. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.04.063 · Cited by 214 · see citing works
Sterne, J. A. C., Bodalia, P. N., Bryden, P. A., Davies, P. A., López-López, J. A., Okoli, G. N., Thom, H. H. Z., Caldwell, D. M., Dias, S., Eaton, D., et al. (2017) · Health Technology Assessment · doi:10.3310/hta21090 · Cited by 201 · see citing works
Gómez‐Outes, A., Terleira‐Fernández, A. I., Calvo, G., Suárez‐Gea, M. L., & Vargas, E. (2013) · Thrombosis · doi:10.1155/2013/640723 · Cited by 185 · see citing works
Atrial fibrillation and stroke prevention: 25 years of research at EP Europace journal
Lip, G. Y. H., Proietti, M., Potpara, T., MANSOUR, M. C., Savelieva, I., Tse, H., Goette, A., Camm, A. J., Blomström‐Lundqvist, C., Gupta, D., et al. (2023) · EP Europace · doi:10.1093/europace/euad226 · Cited by 171 · see citing works
Self-citationDiener, H., Easton, J. D., Granger, C. B., Cronin, L., Duffy, C., Cotton, D., Brueckmann, M., & Sacco, R. L. (2015) · International Journal of Stroke · doi:10.1111/ijs.12630 · Cited by 166 · see citing works
Self-citationDiener, H., Aisenberg, J., Ansell, J., Atar, D., BREITHARDT, G. E., Eikelboom, J. W., Ezekowitz, M. D., Granger, C. B., Halperin, J. L., Hohnloser, S. H., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw069 · Cited by 140 · see citing works
Self-citationReview and update of the concept of embolic stroke of undetermined source
Diener, H., Easton, J. D., Hart, R. G., Kasner, S. E., Kamel, H., & Ntaios, G. (2022) · Nature Reviews Neurology · doi:10.1038/s41582-022-00663-4 · Cited by 115 · see citing works
Self-citationBrown, D. G., Wilkerson, E. C., & Love, W. E. (2014) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2014.10.027 · Cited by 102 · see citing works
Secondary stroke prevention in people with atrial fibrillation: treatments and trials
Seiffge, D. J., Cancelloni, V., Räber, L., Paciaroni, M., Metzner, A., Kirchhof, P. F., Fischer, U., Werring, D. J., Shoamanesh, A., & Caso, V. (2024) · The Lancet Neurology · doi:10.1016/s1474-4422(24)00037-1 · Cited by 98 · see citing works
Antithrombotic therapy for stroke prevention in non-valvular atrial fibrillation
Alberts, M. J., Eikelboom, J. W., & Hankey, G. J. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70258-2 · Cited by 79 · see citing works
Self-citationElevation of brain-enriched miRNAs in cerebrospinal fluid of patients with acute ischemic stroke
Sørensen, S. S., Nygaard, A., Carlsen, A. L., Heegaard, N. H. H., Bak, M., & Christensen, T. (2017) · Biomarker Research · doi:10.1186/s40364-017-0104-9 · Cited by 78 · see citing works
Diamantopoulos, A., Sawyer, L., Lip, G. Y. H., Witte, K. K., Reynolds, M. R., Fauchier, L., Thijs, V., Brown, B., Angulo, M. E. Q., & Diener, H. (2016) · International Journal of Stroke · doi:10.1177/1747493015620803 · Cited by 78 · see citing works
Self-citationDirect-Acting Oral Anticoagulants and Their Reversal Agents—An Update
Kustos, S. A., & Fasinu, P. S. (2019) · Medicines · doi:10.3390/medicines6040103 · Cited by 63 · see citing works
Hohnloser, S. H., Basic, E., & Näbauer, M. (2019) · Thrombosis and Haemostasis · doi:10.1055/s-0039-1683428 · Cited by 61 · see citing works
Self-citationOutcomes of patients with atrial fibrillation and ischemic stroke while on oral anticoagulation
Benz, A. P., Hohnloser, S. H., Eikelboom, J. W., Carnicelli, A., Giugliano, R. P., Granger, C. B., Harrington, J., Hijazi, Z., Morrow, D. A., Patel, M. R., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad200 · Cited by 60 · see citing works
Self-citationPotential Cost-Effectiveness of Ambulatory Cardiac Rhythm Monitoring After Cryptogenic Stroke
Yong, J. H. E., Thavorn, K., Hoch, J. S., Mamdani, M., Thorpe, K. E., Dorian, P., Sharma, M., Laupacis, A., & Gladstone, D. J. (2016) · Stroke · doi:10.1161/strokeaha.115.011979 · Cited by 54 · see citing works
Shoamanesh, A., Field, T. S., Coutts, S. B., Sharma, M., Gladstone, D. J., Hart, R. G., Boriani, G., Wright, D. J., Sticherling, C., Birnie, D. H., et al. (2025) · The Lancet Neurology · doi:10.1016/s1474-4422(24)00475-7 · Cited by 53 · see citing works
Self-citationResidual Risk of Recurrent Stroke Despite Anticoagulation in Patients With Atrial Fibrillation
McCabe, J. J., Cheung, Y., Foley, M., Brennan, S. O., Buckley, J., Camps‐Renom, P., Cassidy, T., Collins, R., Dolan, E., Große, G. M., et al. (2025) · JAMA Neurology · doi:10.1001/jamaneurol.2025.1337 · Cited by 52 · see citing works
Self-citationOral Anticoagulant Therapy in Atrial Fibrillation Patients at High Stroke and Bleeding Risk
Potpara, T., & Lip, G. Y. H. (2015) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2015.07.003 · Cited by 51 · see citing works
Self-citationAtrial fibrillation genetic risk differentiates cardioembolic stroke from other stroke subtypes
Pulit, S. L., Weng, L.-C. C., McArdle, P. F., Trinquart, L., Choi, S. H., Mitchell, B. D., Rosand, J. M., de Bakker, P. I. W., Benjamin, E. J., Ellinor, P. T., et al. (2018) · Neurology Genetics · doi:10.1212/nxg.0000000000000293 · Cited by 50 · see citing works
Atrial Fibrillation and Stroke
Essa, H., Hill, A. M., & Lip, G. Y. H. (2021) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2020.11.003 · Cited by 53 · see citing works
Self-citationKo, D., Cove, C. L., & Hylek, E. M. (2014) · Thrombosis and Haemostasis · doi:10.1160/th13-12-1032 · Cited by 46 · see citing works
Antiplatelet agents for chronic kidney disease
Natale, P., Palmer, S. C., Saglimbene, V. M., Ruospo, M., Razavian, M., Craig, J. C., Jardine, M., Webster, A. C., & Strippoli, G. F. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008834.pub4 · Cited by 45 · see citing works
Sherzai, A. Z., & Elkind, M. S. V. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12723 · Cited by 42 · see citing works
New anticoagulant treatments to protect against stroke in atrial fibrillation
Potpara, T., Lip, G. Y. H., & Apostolakis, S. Z. (2012) · Heart · doi:10.1136/heartjnl-2012-301841 · Cited by 41 · see citing works
Self-citationDiener, H., Hankey, G. J., Easton, J. D., Lip, G. Y. H., Hart, R. G., & Caso, V. (2020) · European Heart Journal Supplements · doi:10.1093/eurheartj/suaa104 · Cited by 38 · see citing works
Self-citationKirchhof, P., Schmalowsky, J., Pittrow, D., Rosin, L., Kirch, W., Wegscheider, K., Meinertz, T., & for the ATRIUM Study Group (2014) · Clinical Cardiology · doi:10.1002/clc.22272 · Cited by 37 · see citing works
2025 Clinical practice guidelines for Atrial fibrillation and flutter
Golukhova, E. Z., Sp, G., Михайлов, Е. Н., Revishvili, A. S. H., Arakelyan, M. G., Vasilyeva, E. Y., Davtyan, K. V., Drapkina, O. M., Drozdova, L. Y., Станиславовна, К. Е., et al. (2026) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2025-6668 · Cited by 44 · see citing works
Kent, D. M., Leung, L. Y., Zhou, Y., Luetmer, P. H., Kallmes, D. F., Nelson, J., Fu, S., Zheng, C., Liu, H., & Chen, W. (2021) · Neurology · doi:10.1212/wnl.0000000000012602 · Cited by 37 · see citing works
Novel oral anticoagulants in non-valvular atrial fibrillation
Potpara, T., & Lip, G. Y. H. (2013) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2013.07.008 · Cited by 36 · see citing works
Self-citationHæusler, K. G., Kirchhof, P. F., Heuschmann, P. U., Laufs, U., Busse, O., Kunze, C., Thomalla, G., Nabavi, D. G., Röther, J., Veltkamp, R. C., et al. (2015) · American Heart Journal · doi:10.1016/j.ahj.2015.10.010 · Cited by 36 · see citing works
Johnson, L., Benz, A. P., Shoamanesh, A., Eikelboom, J. W., Ezekowitz, M. D., Giugliano, R. P., Wallentin, L. C., Ruff, C. T., Lópes, R. D., Jolly, S. S., et al. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.123.034758 · Cited by 31 · see citing works
Self-citationPermanent Percutaneous Carotid Artery Filter to Prevent Stroke in Atrial Fibrillation Patients
Reddy, V. Y., Neužil, P., Potter, T. J. R. D., der Heyden, J. V., Tromp, S. C., Rensing, B. J. W. M., Jirešová, E., Dujka, L., & Lekešová, V. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.04.035 · Cited by 30 · see citing works
Anticoagulant therapy for patients with ischaemic stroke
Hankey, G. J. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.77 · Cited by 30 · see citing works
Self-citationNovel oral anticoagulants for the secondary prevention of cerebral ischemia: a network meta-analysis
Katsanos, A. H., Mavridis, D., Parissis, J., Deftereos, S. G., Frogoudaki, A., Vrettou, A., Ikonomidis, I., Chondrogianni, M. E., Safouris, A., Filippatou, A. G., et al. (2016) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285616659411 · Cited by 28 · see citing works
Huang, W., Singer, D. E., Wu, Y., Chiang, C., Weng, H., Lee, M., & Ovbiagele, B. I. (2018) · JAMA Neurology · doi:10.1001/jamaneurol.2018.2215 · Cited by 28 · see citing works
The Evolving Concept of Cryptogenic Stroke
Kamel, H. (2020) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000000832 · Cited by 27 · see citing works
Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomström‐Lundqvist, C., Boriani, G., Castellà, M., Dan, G., Dilaveris, P., et al. (2021) · Revista Española de Cardiología · doi:10.1016/j.recesp.2020.10.022 · Cited by 28 · see citing works
Self-citationSawyer, L., Witte, K. K., Reynolds, M. R., Mittal, S., Jones, F. G., Rosemas, S. C., Ziegler, P., Kaplon, R. E., & Yaghi, S. R. (2020) · Journal of Comparative Effectiveness Research · doi:10.2217/cer-2020-0224 · Cited by 26 · see citing works
Management of ischaemic stroke in the acute setting : review of the current status : review article
Jivan, K., Ranchod, K., & Modi, G. (2013) · Cardiovascular journal of South Africa/Cardiovascular journal of Southern Africa · doi:10.5830/cvja-2013-001 · Cited by 26 · see citing works
The effect of aspirin on mean platelet volume in patients with paroxysmal atrial fibrillation
Çölkesen, Y., Coskun, I., & Müderrisoğlu, H. (2012) · Platelets · doi:10.3109/09537104.2012.682106 · Cited by 26 · see citing works
Edwards, S. J., Wakefield, V., Jhita, T., Kew, K. M., Cain, P., & Marceniuk, G. (2020) · Health Technology Assessment · doi:10.3310/hta24050 · Cited by 25 · see citing works
Embolic Stroke of Undetermined Source
Sposato, L. A., Sur, N. B., Mira, K., Johansen, M. C., Marchis, G. M. D., Caso, V., Fischer, U., & Chaturvedi, S. (2024) · Neurology · doi:10.1212/wnl.0000000000209535 · Cited by 23 · see citing works
Burkowitz, J., Merzenich, C., Grassme, K. S., & Brüggenjürgen, B. (2016) · European Journal of Preventive Cardiology · doi:10.1177/2047487316632628 · Cited by 22 · see citing works
Effect of statin use on clinical outcomes in ischemic stroke patients with atrial fibrillation
Wu, Y., Saver, J. L., Chen, P., Lee, J.-D., Wang, H., Rao, N. M., Lee, M., & Ovbiagele, B. (2017) · Medicine · doi:10.1097/md.0000000000005918 · Cited by 22 · see citing works
Direct-Acting Oral Anticoagulants in Critically Ill Patients
Rali, P. M., Gangemi, A. J., Moores, A., Mohrien, K. M., & Moores, L. K. (2019) · CHEST Journal · doi:10.1016/j.chest.2019.05.025 · Cited by 22 · see citing works
Hamann, G. F., Sander, D., Grau, A., & Röther, J. (2022) · DGNeurologie · doi:10.1007/s42451-022-00461-8 · Cited by 21 · see citing works
Management of Embolic Stroke of Undetermined Source (ESUS)
Geisler, T., Mengel, A., Ziemann, U., & Poli, S. (2018) · Drugs · doi:10.1007/s40265-018-0912-8 · Cited by 20 · see citing works
Non-vitamin-K oral anticoagulants (NOACs) for the prevention of secondary stroke
Diener, H., Ntaios, G., O'Donnell, M. J., & Easton, J. D. (2018) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2018.1515913 · Cited by 20 · see citing works
Self-citationHuppertz, A., Grond‐Ginsbach, C., Dumschat, C., Foerster, K. I., Burhenne, J., Weiß, J., Czock, D., Purrucker, J. C., Rizos, T., & Haefeli, W. E. (2019) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-019-0331-9 · Cited by 20 · see citing works
The unappreciated importance of blood pressure in recent and older atrial fibrillation trials
Manolis, A. J., Doumas, M. N., Poulimenos, L. E., Kallistratos, M. S., & Mancia, G. (2013) · Journal of Hypertension · doi:10.1097/hjh.0b013e3283638194 · Cited by 20 · see citing works
Tanislav, C., Milde, S., Schwartzkopff, S., Misselwitz, B., Sieweke, N., & Kaps, M. (2015) · BMC Research Notes · doi:10.1186/s13104-015-1237-2 · Cited by 19 · see citing works
Keating, G. M. (2013) · Drugs · doi:10.1007/s40265-013-0063-x · Cited by 18 · see citing works
Shoamanesh, A., Charidimou, A., Sharma, M., & Hart, R. G. (2017) · Stroke · doi:10.1161/strokeaha.117.018467 · Cited by 18 · see citing works
Self-citationNovel Oral Anticoagulants for Atrial Fibrillation
Hankey, G. J., & Eikelboom, J. W. (2013) · Current Atherosclerosis Reports · doi:10.1007/s11883-013-0344-6 · Cited by 17 · see citing works
Self-citationMaervoet, J., Bossers, N., Borge, R. P., Hilpert, S. T., van Engen, A., & Smala, A. M. (2019) · Journal of Medical Economics · doi:10.1080/13696998.2019.1663355 · Cited by 17 · see citing works
Kongnakorn, T., Lanitis, T., Annemans, L., Thijs, V., & Marbaix, S. (2014) · Clinical Drug Investigation · doi:10.1007/s40261-014-0224-z · Cited by 16 · see citing works
Kim, A., Kamel, H., Bernstein, R. A., Manchanda, M., & Caprio, F. Z. (2022) · Stroke · doi:10.1161/strokeaha.122.037342 · Cited by 16 · see citing works
Non-Vitamin K Oral Anticoagulants in Stroke Patients: Practical Issues
Diener, H., & Kleinschnitz, C. (2016) · Journal of Stroke · doi:10.5853/jos.2016.00157 · Cited by 14 · see citing works
Self-citationIntracranial Hemorrhage Risk in the Era of Antithrombotic Therapies for Ischemic Stroke
Thon, J. M., & Gurol, M. E. (2016) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-016-0453-y · Cited by 14 · see citing works
Apixaban to prevent stroke in patients with atrial fibrillation: a review
Peterson, B. E., Al‐Khatib, S. M., & Granger, C. B. (2016) · Therapeutic Advances in Cardiovascular Disease · doi:10.1177/1753944716652787 · Cited by 14 · see citing works
Sejr, M. H., May, O., Damgaard, D., Sandal, B. F., & Nielsen, J. C. (2019) · Heart · doi:10.1136/heartjnl-2018-314186 · Cited by 14 · see citing works
COCCHERI, S., & Orlando, D. (2012) · Internal and Emergency Medicine · doi:10.1007/s11739-012-0886-6 · Cited by 13 · see citing works
Diener, H.-C. (2013) · Thrombosis and Haemostasis · doi:10.1160/th13-04-0277 · Cited by 13 · see citing works
Self-citationManagement of patients with stroke treated with direct oral anticoagulants
Seiffge, D. J., Polymeris, A. A., Fladt, J. C., Lyrer, P. A., Engelter, S. T., & Marchis, G. M. D. (2018) · Journal of Neurology · doi:10.1007/s00415-018-9061-y · Cited by 13 · see citing works
Anti-thrombotic therapy in patients with atrial fibrillation and intracranial hemorrhage
Diener, H.-C., Stanford, S., Abdul-Rahim, A., Christensen, L., Hougaard, K. D., Bakhai, A., Veltkamp, R., & Worthmann, H. (2014) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2014.945435 · Cited by 12 · see citing works
Self-citationRole of apixaban (eliquis) in the treatment and prevention of thromboembolic disease.
Budovich, A., Zargarova, O., & Nogid, A. (2013) · Europe PMC (PubMed Central) · Cited by 12 · see citing works
Sehgal, V., Bajwa, S. S., & Bajaj, A. (2013) · Annals of Cardiac Anaesthesia · doi:10.4103/0971-9784.114244 · Cited by 12 · see citing works
Lindsberg, P. J., Toivonen, L. K., & Diener, H. (2014) · BMC Medicine · doi:10.1186/s12916-014-0180-8 · Cited by 12 · see citing works
Self-citationErwin, J. P., & Iung, B. (2018) · Heart · doi:10.1136/heartjnl-2017-312758 · Cited by 12 · see citing works
Li, Y., Pastori, D., & Lip, G. Y. H. (2018) · Annals of Medicine · doi:10.1080/07853890.2018.1460489 · Cited by 11 · see citing works
Self-citationSejr, M. H., Nielsen, J. C., Damgaard, D., Sandal, B. F., & May, O. (2017) · Journal of Electrocardiology · doi:10.1016/j.jelectrocard.2017.01.009 · Cited by 11 · see citing works
Thijs, V., Witte, K. K., Guarnieri, C., Makino, K., Tilden, D., Gillespie, J., & Huynh, M. (2021) · Journal of Arrhythmia · doi:10.1002/joa3.12586 · Cited by 9 · see citing works
Management and Prognosis of Acute Stroke in Atrial Fibrillation
Hindsholm, M. F., Damgaard, D., Gurol, M. E., Gaist, D., & Simonsen, C. Z. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12175752 · Cited by 11 · see citing works
Palm, F., Kraus, M., Safer, A., Wolf, J., Becher, H., & Grau, A. (2014) · BMC Neurology · doi:10.1186/s12883-014-0199-7 · Cited by 10 · see citing works
Association between implantable loop recorder use and secondary stroke prevention: a meta-analysis
Huang, W., Ovbiagele, B. I., Hsieh, C., & Lee, M. (2022) · Open Heart · doi:10.1136/openhrt-2022-002034 · Cited by 10 · see citing works
Antithrombotic and Anticoagulant Therapy for Atrial Fibrillation
Dzeshka, M. S., & Lip, G. Y. H. (2016) · Heart Failure Clinics · doi:10.1016/j.hfc.2015.08.021 · Cited by 10 · see citing works
Self-citationImportance of Finding Embolic Sources for Patients with Embolic Stroke of Undetermined Source
Umemura, T., Nishizawa, S., Nakano, Y., Saito, T., Kitagawa, T., Miyaoka, R., Suzuki, K., & Yamamoto, J. (2019) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2019.04.022 · Cited by 10 · see citing works
Novel oral anticoagulants in secondary prevention of stroke
Diener, H., Easton, J. D., Hankey, G. J., & Hart, R. G. (2013) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2013.07.007 · Cited by 9 · see citing works
Self-citationAntithrombotic and Anticoagulant Therapy for Atrial Fibrillation
Dzeshka, M. S., & Lip, G. Y. H. (2014) · Cardiology Clinics · doi:10.1016/j.ccl.2014.07.009 · Cited by 9 · see citing works
Self-citationThe MAGIC Study Group, Uchiyama, S., Goto, S., Origasa, H., Uemura, N., Sugano, K., Hiraishi, H., Shimada, K., Okada, Y., & Ikeda, Y. (2019) · Heart and Vessels · doi:10.1007/s00380-019-01484-0 · Cited by 9 · see citing works
Jung, K., Yu, K., Kim, Y. D., Park, J. M., Hong, K., Rha, J., Kwon, S. U., Bae, H., Heo, J. H., Lee, B. C., et al. (2015) · Journal of Stroke · doi:10.5853/jos.2015.17.2.210 · Cited by 9 · see citing works
Alcocer, L. A. (2016) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-016-0163-6 · Cited by 9 · see citing works
Eriksson, S. (2016) · Brain and Behavior · doi:10.1002/brb3.603 · Cited by 9 · see citing works
Lee, A., & Rajaratnam, R. (2014) · Journal of Neurology & Neurophysiology · doi:10.4172/2155-9562.1000248 · Cited by 8 · see citing works
Permanent Bilateral Carotid Filters for Stroke Prevention in Atrial Fibrillation
Potter, T. J. R. D., Yodfat, O., Shinar, G., Neta, A., Reddy, V. Y., Neužil, P., Veltkamp, R. C., & Connolly, S. J. (2020) · Current Cardiology Reports · doi:10.1007/s11886-020-01388-w · Cited by 8 · see citing works
Self-citationPezawas, T. (2023) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd10070306 · Cited by 10 · see citing works
Latest developments in anticoagulant drug discovery
Broussalis, E., Anna, W., Trinka, E., Mutzenbach, J. S., & Killer‐Oberpfalzer, M. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.02.011 · Cited by 8 · see citing works
Platelet Antiaggregants in Stroke Prevention
Vidal, S. G. M., & Ruland, S. D. (2013) · Neurologic Clinics · doi:10.1016/j.ncl.2013.03.004 · Cited by 8 · see citing works
- Authors
- Diener, H.-C., Eikelboom, J., Connolly, S. J., Joyner, C. D., Hart, R. G., Lip, G. Y., O'Donnell, M., Hohnloser, S. H., Hankey, G. J., Shestakovska, O., & Yusuf, S.
- Affiliations
- Essen University Hospital (DE)
- Population Health Research Institute (CA)
- University of Toronto (CA)
- Birmingham City Hospital (GB)
- Health Research Board (IE)
- Goethe University Frankfurt (DE)
- Royal Perth Hospital (AU)
- Corresponding author
- Diener, Hans-Christoph
- ORCID
- Venue
- The Lancet Neurology
- Publisher
- Elsevier BV
- Published
- 2012-03
- Volume
- 11
- Issue
- 3
- Pages
- 225-231
- ISSN
- 1474-4422 (ISSN-L)
- OpenAlex
- W2110222797
- Cited by
- 177
- References
- 15
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 7 · 2023: 9 · 2022: 10 · 2021: 6 · 2020: 14 · 2019: 15 · 2018: 10 · 2017: 9 · 2016: 17 · 2015: 13 · 2014: 20 · 2013: 20 · 2012: 19
- FWCI
- 14.82
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- Locations
- The Lancet Neurology (publishedVersion)
- PubMed (publishedVersion)
- UWA Profiles and Research Repository (UWA) (submittedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- RUNA. Repositorio Institucional del Sergas (Servicio Gallego de Salud (SERGAS)) (submittedVersion, other-oa)
- Funders
- Bristol-Myers Squibb
- Pfizer
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Health Sciences › Medicine › Epidemiology › Acute Ischemic Stroke Management
- Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
- Keywords
- apixaban, aspirin, atrial fibrillation, stroke prevention, transient ischemic attack, stroke history, factor Xa inhibitors, major bleeding, systemic embolism, subgroup analysis, AVERROES trial, anticoagulation, antiplatelet therapy, risk stratification, bleeding risk stratification
- MeSH terms
- Aged, Aged, 80 and over, Aspirin, Atrial Fibrillation, Ischemic Attack, Transient, Female, Fibrinolytic Agents, Humans, Male, Middle Aged, Pyrazoles, Pyridones, Treatment Outcome, Stroke
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
